NIH-funded research R01 grant

Understanding how clinician decisions affect hypertension control across different groups

Official title: Clinician Concordance with Hypertension Treatment Guidelines: Variation by Patient, Physician, Clinic, and Geographic Factors and Associations with Blood Pressure Control

Funded at Vanderbilt University Medical Center · NIH-11365929 · Data updated 2026-11-12

Doctors’ adherence to hypertension guidelines varies and this study looks at how that impacts blood pressure control among different races and regions.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startSeptember 1, 2024
Project endJune 30, 2028
Funding year2026
Award (this year)$416,826
NIH project number5R01HL173523-03
Project IDNIH-11365929 on NIH RePORTER

Who could benefit from this research

Could help

Adults with hypertension treated in varied clinical settings, particularly Black, Hispanic, Asian, and White populations in the Southeastern US.

Less likely to help

Patients not receiving active hypertension management or not represented in the dataset may see limited direct benefit.

What this research studies

This project analyzes how closely clinicians follow national hypertension guidelines in real-world settings and how that relates to blood pressure control among Black, Hispanic, Asian, and White patients. Researchers will examine patient, physician, clinic, and geographic factors to identify where guideline concordance breaks down. The goal is to pinpoint practical steps that could help clinicians follow evidence-based treatment more consistently, potentially improving BP control for diverse patients. The study uses existing data sources and could inform targeted strategies to reduce racial disparities in hypertension outcomes.

Why it matters

Potential benefit: If successful, the findings could guide clinicians toward more guideline-concordant care, improving blood pressure control for patients across racial groups.

How similar studies have gone: Prior research suggests that guideline-concordant treatment improves BP control, but persistent disparities indicate the need for contextual understanding; this study adds real-world nuance.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Tedla, Yacob G — Vanderbilt University Medical Center
  • Study coordinator: Tedla, Yacob G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.